search
Back to results

Hysteroscopic Septoplasty by Different Modalities

Primary Purpose

Septate Uterus, Recurrent Pregnancy Loss, Subfertility

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Hysteroscopic septoplasty with scissors
Hysteroscopic septoplasty with resectoscope
Sponsored by
Mansoura University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Septate Uterus

Eligibility Criteria

18 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria: Women of reproductive age Seeking conception Diagnosis of a septate or subseptate uterus A history of one of the following: Recurrent pregnancy loss Subfertility Preterm Birth Exclusion Criteria: Not seeking conception Diagnosis of septate or subseptate uterus with no history of any of the following: Recurrent pregnancy loss Subfertility Preterm Birth Contraindications for surgery Those who refused to participate.

Sites / Locations

  • Faculty of medicine, Mansoura university

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Scissors arm

Resectoscope arm

Arm Description

Patients in this group had undergone resection of the septum with hysteroscope and scissors, The scissors used was pointed, single action and semi rigid . Saline was used as the distending medium in the scissors group. Septal incision was carried out using shortening technique by incising the septum at the leading edge and continue dividing by moving from side to side (in narrow septum), or by thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other (in broad septum). The operation was stopped if the fluid deficit exceeded 2500 ml of saline.

Patients in this group had undergone resection of the septum with Monopolar 26 French resectoscope Dilation of cervical os with Hegar's dilator (up to hegar 8 or 9) , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 40-70 Watt) and glycine 1.5% as the distension medium, using shortening or thinning incision. The operation was stopped if the fluid deficit exceeded 1000 ml of glycine. The delivery of distension media was conducted by automated pressure delivery system. All patients were prescribed cyclic estrogen and progesterone for two months.

Outcomes

Primary Outcome Measures

Operative time
Fluid deficit
Operative and post operative complications
Need for second intervention

Secondary Outcome Measures

Pregnancy rate
Live birth rate

Full Information

First Posted
March 22, 2023
Last Updated
April 6, 2023
Sponsor
Mansoura University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05802784
Brief Title
Hysteroscopic Septoplasty by Different Modalities
Official Title
Hysteroscopic Septoplasty by Different Modalities: A Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
June 16, 2020 (Actual)
Primary Completion Date
March 1, 2023 (Actual)
Study Completion Date
March 21, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare in participant population ( women with uterine septum meeting the inclusion criteria) hysteroscopic septoplasty by resectoscope compared to hysteroscopic septoplasty with scissors. The main questions to answer are: Is there a difference in operative time ? Is there a difference in fluid used and fluid deficit? Is there a difference in complications? Is there a difference in reproductive outcome? Researchers will compare the 2 different techniques to see if there is any difference in operative outcome ( operative time, fluid used and deficit, need for second intervention, and operative and postoperative complications) and reproductive outcome.
Detailed Description
Study design: Prospective randomized clinical trial Study duration and location: For at least 24 months, Patients admitted to Obstetrics and Gynecology department at Mansoura University Hospital. Study method At baseline, the following will be done: History taking: personal history, menstrual history, obstetrical and gynecological history, present and past history. Patient presentation (subfertility or pregnancy loss) Physical examination: General, abdominal and local examination. Diagnosis of uterine septum either by hysterosalpingogram (HSG), Three dimensional transvaginal ultrasound or office hysteroscopy. Thereafter: Patients will be prospectively recruited and randomized by computer program to 2 groups Group A: Patients in this group will undergo resection of the septum with hysteroscope and scissors. Saline will be used as a distending medium in the scissors group. Septal incision will be carried out using a thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other Group B: Patients in this group will undergo resection of the septum with monopolar resectoscope , dilation of cervical os with Hegar's dilators , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 50-70 Watt) and glycine 1.5% as the distension medium Sample size calculation Sample size was calculated using Power Analysis and Sample Size software program (PASS) version 15.0.5 for windows (2017) using the results published before with the operative duration of hysteroscopic incision in septate uterus by scissors compared to resectoscope as the primary outcome. The study reported the median operative duration as 10 minutes for resectoscope while that for scissors was 30 minutes. The null hypothesis was considered as the absence of difference between both groups regarding the operative duration. A sample size of 16 patients in each group is needed to achieve 95% power (1-β or the probability of rejecting the null hypothesis when it is false) in the proposed study using a two-sided Fisher exact test with a significance level (α or the probability of rejecting the null hypothesis when it is true) of 5% and hypothesized common standard deviation 15 in both groups. 4 patients drop-out is expected, so a total of 20 patients will be enrolled to each group Statistical analysis Data will be analyzed using the Statistical Package of Social Science (SPSS) program for Windows (Standard version 24). The normality of data will be first tested with one-sample Kolmogorov-Smirnov test. Qualitative data will be described using number and percent. Continuous variables will be presented as mean ± standard deviation for normally distributed data and median (IQR) for non-normal data. The following tests will be used; Chi square test: Compare qualitative variables. Fisher exact test and monte carlo test: Compare qualitative variables when expected count less than 5. Independent t- test: Compare two quantitative variables (parametric). Mann Whitney test: Compare two quantitative variables (Non parametric). For all above mentioned statistical tests , the threshold of significance is fixed at 5% level.The results was considered significant when p ≤ 0.05. The smaller the p-value obtained, the more significant are the results. Ethical consideration: Study protocol was submitted for approval by Institutional Review Board Approval of the managers of the health care facilities in which the study was conducted. Informed written consent will be obtained from each participant sharing in the study. Confidentiality and personal privacy will be respected in all levels of the study. Collected data will not be used for any other purpose.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septate Uterus, Recurrent Pregnancy Loss, Subfertility

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Scissors arm
Arm Type
Active Comparator
Arm Description
Patients in this group had undergone resection of the septum with hysteroscope and scissors, The scissors used was pointed, single action and semi rigid . Saline was used as the distending medium in the scissors group. Septal incision was carried out using shortening technique by incising the septum at the leading edge and continue dividing by moving from side to side (in narrow septum), or by thinning technique by which incisions will be made along each side of the septum alternately from one cornual end to the other (in broad septum). The operation was stopped if the fluid deficit exceeded 2500 ml of saline.
Arm Title
Resectoscope arm
Arm Type
Active Comparator
Arm Description
Patients in this group had undergone resection of the septum with Monopolar 26 French resectoscope Dilation of cervical os with Hegar's dilator (up to hegar 8 or 9) , incision of the septum using a resectoscope with the Collins knife, monopolar energy (cut 40-70 Watt) and glycine 1.5% as the distension medium, using shortening or thinning incision. The operation was stopped if the fluid deficit exceeded 1000 ml of glycine. The delivery of distension media was conducted by automated pressure delivery system. All patients were prescribed cyclic estrogen and progesterone for two months.
Intervention Type
Procedure
Intervention Name(s)
Hysteroscopic septoplasty with scissors
Intervention Description
In hysteroscopic septoplasty with scissors arm, incision of the septum was done by continuous flow hysteroscopy and scissors using saline as distension media.
Intervention Type
Procedure
Intervention Name(s)
Hysteroscopic septoplasty with resectoscope
Intervention Description
In hysteroscopic septoplasty with resectoscope arm, incision of the septum was done by 26 Fr monopolar resectoscope with collin's knife using glycine1.5% as distension media.
Primary Outcome Measure Information:
Title
Operative time
Time Frame
During surgery
Title
Fluid deficit
Time Frame
During surgery
Title
Operative and post operative complications
Time Frame
3 months follow up after intervention
Title
Need for second intervention
Time Frame
3 months follow up after intervention
Secondary Outcome Measure Information:
Title
Pregnancy rate
Time Frame
At least 6 months follow up after intervention
Title
Live birth rate
Time Frame
Follow up until the end of first clinical pregnancy or 6 months after surgery

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women of reproductive age Seeking conception Diagnosis of a septate or subseptate uterus A history of one of the following: Recurrent pregnancy loss Subfertility Preterm Birth Exclusion Criteria: Not seeking conception Diagnosis of septate or subseptate uterus with no history of any of the following: Recurrent pregnancy loss Subfertility Preterm Birth Contraindications for surgery Those who refused to participate.
Facility Information:
Facility Name
Faculty of medicine, Mansoura university
City
Mansoura
State/Province
Dakahlia
ZIP/Postal Code
35511
Country
Egypt

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Hysteroscopic Septoplasty by Different Modalities

We'll reach out to this number within 24 hrs